United States (US) Cell And Gene Therapy Clinical Trial Services Market (2025-2031) | Segmentation, Share, Size & Revenue, Analysis, Growth, Trends, Forecast, Companies, Industry, Outlook, Competitive Landscape, Value

Name: United States (US) Cell And Gene Therapy Clinical Trial Services Market (2025-2031) | Segmentation & Share
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Service (Site Identification, Patient Recruitment, Laboratory Services, Regulatory Services, Supply and Logistic Services, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Areas (Oncology, Central Nervous System (CNS) Disorders, Cardiovascular Diseases, Infectious Diseases, Musculoskeletal, Others), By Therapy Type (Gene Therapy, Gene-modified Cell Therapy, Cell Therapy, Others) And Competitive Landscape

Product Code: ETC9962027	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Cell And Gene Therapy Clinical Trial Services Market Outlook
Market Size of United States (US) Cell And Gene Therapy Clinical Trial Services Market, 2024
Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market, 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Revenues & Volume for the Period 2021- 2031
United States (US) Cell And Gene Therapy Clinical Trial Services Market Trend Evolution
United States (US) Cell And Gene Therapy Clinical Trial Services Market Drivers and Challenges
United States (US) Cell And Gene Therapy Clinical Trial Services Price Trends
United States (US) Cell And Gene Therapy Clinical Trial Services Porter's Five Forces
United States (US) Cell And Gene Therapy Clinical Trial Services Industry Life Cycle
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Service for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Site Identification for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Patient Recruitment for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Laboratory Services for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Regulatory Services for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Supply and Logistic Services for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Phase for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Phase I for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Phase II for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Phase III for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Phase IV for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Therapeutic Areas for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Oncology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Central Nervous System (CNS) Disorders for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Cardiovascular Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Musculoskeletal for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Therapy Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Gene Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Gene-modified Cell Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Cell Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Cell And Gene Therapy Clinical Trial Services Import Export Trade Statistics
Market Opportunity Assessment By Service
Market Opportunity Assessment By Phase
Market Opportunity Assessment By Therapeutic Areas
Market Opportunity Assessment By Therapy Type
United States (US) Cell And Gene Therapy Clinical Trial Services Top Companies Market Share
United States (US) Cell And Gene Therapy Clinical Trial Services Competitive Benchmarking By Technical and Operational Parameters
United States (US) Cell And Gene Therapy Clinical Trial Services Company Profiles
United States (US) Cell And Gene Therapy Clinical Trial Services Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Cell And Gene Therapy Clinical Trial Services Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Cell And Gene Therapy Clinical Trial Services Market - Industry Life Cycle

3.4 United States (US) Cell And Gene Therapy Clinical Trial Services Market - Porter's Five Forces

3.5 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Service, 2021 & 2031F

3.6 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.7 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapeutic Areas, 2021 & 2031F

3.8 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

4 United States (US) Cell And Gene Therapy Clinical Trial Services Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investment in research and development in cell and gene therapy

4.2.2 Growing prevalence of genetic disorders and chronic diseases

4.2.3 Favorable regulatory environment supporting cell and gene therapy advancements

4.3 Market Restraints

4.3.1 High costs associated with cell and gene therapy clinical trials

4.3.2 Complexity and variability in cell and gene therapy processes and technologies

5 United States (US) Cell And Gene Therapy Clinical Trial Services Market Trends

6 United States (US) Cell And Gene Therapy Clinical Trial Services Market, By Types

6.1 United States (US) Cell And Gene Therapy Clinical Trial Services Market, By Service

6.1.1 Overview and Analysis

6.1.2 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Service, 2021- 2031F

6.1.3 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Site Identification, 2021- 2031F

6.1.4 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Patient Recruitment, 2021- 2031F

6.1.5 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Laboratory Services, 2021- 2031F

6.1.6 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Regulatory Services, 2021- 2031F

6.1.7 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Supply and Logistic Services, 2021- 2031F

6.1.8 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Cell And Gene Therapy Clinical Trial Services Market, By Phase

6.2.1 Overview and Analysis

6.2.2 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase I, 2021- 2031F

6.2.3 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase II, 2021- 2031F

6.2.4 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase III, 2021- 2031F

6.2.5 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase IV, 2021- 2031F

6.3 United States (US) Cell And Gene Therapy Clinical Trial Services Market, By Therapeutic Areas

6.3.1 Overview and Analysis

6.3.2 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F

6.3.4 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F

6.3.5 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.6 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Musculoskeletal, 2021- 2031F

6.3.7 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Cell And Gene Therapy Clinical Trial Services Market, By Therapy Type

6.4.1 Overview and Analysis

6.4.2 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.4.3 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene-modified Cell Therapy, 2021- 2031F

6.4.4 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.4.5 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Cell And Gene Therapy Clinical Trial Services Market Import-Export Trade Statistics

7.1 United States (US) Cell And Gene Therapy Clinical Trial Services Market Export to Major Countries

7.2 United States (US) Cell And Gene Therapy Clinical Trial Services Market Imports from Major Countries

8 United States (US) Cell And Gene Therapy Clinical Trial Services Market Key Performance Indicators

8.1 Patient recruitment and retention rates for cell and gene therapy clinical trials

8.2 Success rates of cell and gene therapy treatments in clinical trials

8.3 Time to market for new cell and gene therapy products

9 United States (US) Cell And Gene Therapy Clinical Trial Services Market - Opportunity Assessment

9.1 United States (US) Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Service, 2021 & 2031F

9.2 United States (US) Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Phase, 2021 & 2031F

9.3 United States (US) Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapeutic Areas, 2021 & 2031F

9.4 United States (US) Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

10 United States (US) Cell And Gene Therapy Clinical Trial Services Market - Competitive Landscape

10.1 United States (US) Cell And Gene Therapy Clinical Trial Services Market Revenue Share, By Companies, 2024

10.2 United States (US) Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Cell And Gene Therapy Clinical Trial Services Market

Estonia Cell And Gene Therapy Clinical Trial Services Market

Ethiopia Cell And Gene Therapy Clinical Trial Services Market

Fiji Cell And Gene Therapy Clinical Trial Services Market

Finland Cell And Gene Therapy Clinical Trial Services Market

Gabon Cell And Gene Therapy Clinical Trial Services Market

Global Cell And Gene Therapy Clinical Trial Services Market

Middle East Cell And Gene Therapy Clinical Trial Services Market

North America Cell And Gene Therapy Clinical Trial Services Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here